ArticleBlood2019

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.

Kevin J Curran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.